Dr. Yom is a radiation oncologist who specializes in the treatment of head and neck, skin and thoracic cancers. She is particularly interested in understanding biologic pathways which have impact on the efficacy of radiation therapy and emerging radiotherapeutic and biologic techniques aimed at reducing the toxicities of treatment. In head and neck and skin cancer, she has studied a variety of issues related to chemoradiation and combined modality treatments, technical aspects of radiation delivery, and radiation-related prognostic factors and post-treatment management. Specifically in lung cancer, she has been involved in efforts to quantify the risks of pneumonitis and esophagitis resulting from concurrent treatment with chemotherapy and radiation and established parameters for using intensity-modulated radiation therapy in the treatment of locoregionally advanced lung cancers. She is experienced with many rare tumor types in the head and neck, cutaneous, and thoracic regions.
Awards & Honors
Recent Significant Publications
Ridge JA, Lawson J, Yom SS, Garg MK, McDonald MW, Quon H, Saba N, Salama JK, Smith RV, Worden F, Yeung AR, Beitler JJ. ACR Appropriateness CriteriaŽ Treatment of Stage 1 T1 Glottic Cancer.. Head Neck. 2013 May 21. doi: 10.1002/hed.23381. [Epub ahead of print]
Garg MK, Ridge JA, Yom SS, McDonald MW, Quon H, Smith RV, Yeung AR, Lawson J, Saba N, Salama JK, Beitler JJ. Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer. Head Neck. 2013 Mar;35(3):465-6.
Okoye CC, Jablons DM, Jahan TM, Kukreja J, Cardozo S, Yom SS. Divergent Management Strategies for Typical Versus Atypical Carcinoid Tumors of the Thoracic Cavity. Am J Clin Oncol. 2013 Jan 24.
Dasgupta T, Haas-Kogan DA, Yang X, Olow A, Yang DX, Gragg A, Orloff LA, Yom SS. Genotype-dependent cooperation of ionizing radiation with BRAF inhibition in BRAF V600E-mutated carcinomas. Chemother Res Pract. Invest New Drugs. 2013 Jan 26. [Epub ahead of print].
Saba NF, Yom SS, Haigentz M, El-Rayes B. Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors. Chemother Res Pract. 2012;2012:291421.
Pejavar S, Yom SS, Hwang A, Speight J, Gottschalk A, Hsu IC, Roach M, Xia P. Computer-Assisted, Atlas-Based Segmentation for Target Volume Delineation in Whole Pelvic IMRT for Prostate Cancer. Technol Cancer Res Treat. 2012 Dec 26.
Kono SA, Haigentz M Jr, Yom SS, Saba N. EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab. Chemother Res Pract. 2012;2012:901320.
Graff P, Kirby N, Weinberg V, Chen J, Yom SS, Lambert L, Pouliot J. The Residual Setup Errors of Different IGRT Alignment Procedures for Head and Neck IMRT and the Resulting Dosimetric Impact. Int J Radiat Oncol Biol Phys. 2012 Dec 11.
Graff P, Hu W, Yom SS, Pouliot J. Does IGRT ensure target dose coverage of head and neck IMRT patients? Radiother Oncol. 2012 Jul;104(1):83-90.
Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK. Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck. Int J Radiat Oncol Biol Phys. 2012 Jun 30.
Yom SS, Chen CP, Jahan TM, Jablons DM. One size does not fit all lung cancer patients. J Thorac Oncol. 2012 May;7(5):945.
Yeung AR, Garg MK, Lawson J, McDonald MW, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yom SS, Beitler JJ. ACR Appropriateness Criteria: Ipsilateral Radiation for Squamous Cell Carcinoma of the Tonsil. Head Neck. 2012 May;34(5):613-6.
Chen CP, Weinberg VK, Jahan TM, Jablons DM, Yom SS. Implications of Delayed Initiation of Radiotherapy: Accelerated Repopulation after Induction Chemotherapy for Stage III Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 2011 Nov;6(11):1857-64.
Mannina EM, Pejavar SM, Glastonbury CM, van Zante A, Wang SJ, Yom SS. Diagnosis of Bilateral Tonsil Cancers via Staging PET/CT: Case Report and Review. International Journal of Otolaryngology. 2011;2011:928240. Epub 2011 Jul 14.
Yom SS, Garden AS, Staerkel GA, Ginsberg LE, Morrison WH, Sturgis EM, Rosenthal DI, Myers JN, Edeiken-Monroe BS. Sonographic Examination of the Neck after Definitive Radiotherapy for Node-Positive Oropharyngeal Cancer. American Journal of Neuroradiology. 2011 Sep;32(8):1532-8.
Salama JK, Saba N, Quon H, Garg MK, Lawson J, McDonald MW, Ridge JA, Smith RV, Yeung AR, Yom SS, Beitler JJ. ACR Appropriateness Criteria: Adjuvant Therapy for Resected Squamous Cell Carcinoma of the Head and Neck. Oral Oncology. 2011 Jun;47(7):554-9.
McDonald MW, Lawson J, Garg MK, Quon H, Ridge JA, Saba N, Salama J, Smith RV, Yeung AR, Yom SS, Beitler JJ. ACR Appropriateness Criteria: Retreatment of Recurrent Head and Neck Cancer after Prior Definitive Radiation. International Journal of Radiation Oncology, Biology, Physics. 2011 Aug 1;80(5):1292-8.
Chen CP, Wang SJ, van Zante A, Yom SS. Stepwise Regional and Distant Progression of Recurrent Pleomorphic Adenoma. Journal of Otolaryngology - Head and Neck Surgery 2011;40(1):E5-E10.
Kangelaris G. Yom SS, Huang K, Wang SJ. Limited Utility of Routine Surveillance MRI Following Chemoradiation for Advanced-Stage Oropharynx Carcinoma. International Journal of Otolaryngology 2010. pii: 904297. Epub 2010 Aug 31.
Quon H, Yom SS, Garg MK, Lawson J, McDonald MW, Ridge JA, Saba N, Salama J, Smith R, Yeung AR, Beitler JJ. ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas. Current Problems in Cancer 2010;34 (3):175-92.
Faddegon BA, Aubin M, Bani-Hashemi A, Gangadharan B, Gottschalk AR, Morin O, Sawkey D, Wu V, Yom SS. Comparison of patient megavoltage cone beam CT images acquired with an unflattened beam from a carbon target and a flattened treatment beam. Medical Physics 2010;37(4):1737-41.
Tsuji SY, Hwang A, Weinberg V, Yom SS, Quivey J, Xia P. Adaptive IMRT for Head and Neck Cancer Based on Automatically-Generated Contours Using Deformable Image Registration. International Journal of Radiation Oncology, Biology, Physics 2010;77(3):707-14.
Sawkey D, Lu M, Morin O, Aubin M, Yom SS, Gottschalk AR, Bani-Hashemi A, Faddegon BA. A diamond target for megavoltage cone-beam CT. Medical Physics 2010;37(3):1246-53.
Beadle BM, Jhingran A, Yom SS, Ramirez PT, Eifel PJ. Patterns of Regional Recurrence After Definitive Radiotherapy for Cervical Cancer. International Journal of Radiation Oncology, Biology, Physics 2010;76(5):1396-403.
Park CC, Yom SS, Podgorsak MB, Harris E, Price RA Jr, Bevan A, Pouliot J, Konski AA, Wallner PE; Electronic Brachytherapy Working Group. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee Report on Electronic Brachytherapy. International Journal of Radiation Oncology, Biology, Physics 2010;76(4):963-972.
Cheung J, Aubry JF, Yom SS, Gottschalk AR, Celi JC, Pouliot J. Dose recalculation and the Dose-Guided Radiation Therapy (DGRT) process using megavoltage cone-beam CT. International Journal of Radiation Oncology, Biology, Physics 2009;74(2):583-92.
Hwang AB, Bacharach SL, Yom SS, Weinberg VK, Quivey JM, Franc BL, Xia P. Can Positron Emission Tomography (PET) or PET/Computed Tomography (CT) Acquired in a Nontreatment Position Be Accurately Registered to a Head-and-Neck Radiotherapy Planning CT? International Journal of Radiation Oncology, Biology, Physics 2009;73(2):578-84.
Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, Komaki R, Chen Y, Martel MK, Mohan R, Cox JD, Liao Z. Dose-Volume Thresholds and Smoking Status for the Risk of Treatment-Related Pneumonitis in Inoperable NonSmall Cell Lung Cancer Treated with Definitive Radiotherapy. Radiotherapy and Oncology 2009;91(3):427-32.
Vitolo V, Millender LE, Quivey JM, Yom SS, Schechter NR, Jereczek-Fossa BA, Milani F, Orecchia R, Xia P. Assessment of Carotid Artery Dose in the Treatment of Nasopharyngeal Cancer with IMRT Versus Conventional Radiotherapy. Radiotherapy and Oncology 2009;90(2):213-20.
Huang K, Xia P, Chuang C, Weinberg V, Glastonbury CM, Eisele DW, Lee NY, Yom SS, Phillips TL, Quivey JM. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience. Cancer 2008;113(3):497-507.
Yom SS, Frija EK, Mahajan A, Chang E, Klein K, Shiu A, Ohrt J, Woo SY. Field-in-Field Technique with Intrafractionally Modulated Junction Shifts for Craniospinal Irradiation. International Journal of Radiation Oncology, Biology, Physics 2007;69(4):1193-1198.
Yom SS, Liao Z, Liu H, Liu HH, Tucker SL, Hu C-S, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R. Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics 2007;68(1):94-102.